Abstract
We reported a 71-year-old male patient with multiple liver recurrence of hepatocellular carcinoma, who responded to arterial infusion chemotherapy using CDDP and 5-FU. The patient was administered 10mg/body CDDP and 250 mg/body 5-FU on day 1-5./1 course. As a result, the tumor decreased and AFP was decreased to 50.8 ng/ml (from 93099 ng/ml). The patient is alive 13 months after the beginning of therapy in a condition of partial response (PR).
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Hepatocellular / drug therapy*
-
Cisplatin / administration & dosage
-
Drug Administration Schedule
-
Fluorouracil / administration & dosage
-
Humans
-
Infusion Pumps, Implantable*
-
Infusions, Intra-Arterial
-
Liver Neoplasms / drug therapy*
-
Male
-
Neoplasm Recurrence, Local / drug therapy*
-
Pancreaticoduodenectomy
-
Postoperative Period